R.H. Bluestein & Co’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,524
Closed -$204K 328
2018
Q3
$204K Hold
1,524
0.01% 306
2018
Q2
$243K Sell
1,524
-500
-25% -$74.2K 0.01% 275
2018
Q1
$289K Sell
2,024
-24
-1% -$3.28K 0.02% 255
2017
Q4
$272K Hold
2,048
0.01% 261
2017
Q3
$255K Hold
2,048
0.01% 272
2017
Q2
$288K Hold
2,048
0.02% 229
2017
Q1
$231K Hold
2,048
0.01% 281
2016
Q4
$215K Hold
2,048
0.01% 269
2016
Q3
$258K Hold
2,048
0.02% 231
2016
Q2
$283K Hold
2,048
0.02% 194
2016
Q1
$284K Sell
2,048
-450
-18% -$61.7K 0.02% 205
2015
Q4
$402K Sell
2,498
-24
-1% -$3.71K 0.03% 156
2015
Q3
$336K Hold
2,522
0.02% 202
2015
Q2
$289K Hold
2,522
0.02% 270
2015
Q1
$301K Sell
2,522
-28
-1% -$3.73K 0.02% 259
2014
Q4
$372K Hold
2,550
0.02% 226
2014
Q3
$336K Hold
2,550
0.02% 265
2014
Q2
$319K Hold
2,550
0.02% 274
2014
Q1
$409K Hold
2,550
0.03% 220
2013
Q4
$343K Sell
2,550
-1,550
-38% -$199K 0.02% 246
2013
Q3
$445K Sell
4,100
-500
-11% -$54.1K 0.03% 202
2013
Q2
$390K Buy
+4,600
New +$412K 0.03% 200

Other funds holding ATHN

R.H. Bluestein & Co's ATHN Position: Q4 2018 in Review

R.H. Bluestein & Co sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 1,524 shares — an estimated $204K sold.

R.H. Bluestein & Co first reported a position in ATHN in Q2 2013 and held it in 22 quarters. The position peaked at $445K in Q3 2013. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

  • R.H. Bluestein & Co reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
  • R.H. Bluestein & Co sold 1,524 Athenahealth, Inc. shares in Q4 2018, an estimated $204K.
  • R.H. Bluestein & Co first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 22 quarters.
  • R.H. Bluestein & Co's Athenahealth, Inc. position peaked at $445K in Q3 2013.
  • 263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on R.H. Bluestein & Co's 13F filing for Q4 2018, filed 13 Feb 2019.